NO20060655L - 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn - Google Patents

2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn

Info

Publication number
NO20060655L
NO20060655L NO20060655A NO20060655A NO20060655L NO 20060655 L NO20060655 L NO 20060655L NO 20060655 A NO20060655 A NO 20060655A NO 20060655 A NO20060655 A NO 20060655A NO 20060655 L NO20060655 L NO 20060655L
Authority
NO
Norway
Prior art keywords
alkylidene
vitamin
osteoporosis
male
osteophenia
Prior art date
Application number
NO20060655A
Other languages
English (en)
Inventor
Judith Lee Campagnari
Andrew George Lee
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20060655L publication Critical patent/NO20060655L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse angår metoder for behandling av osteopeni eller mannlig osteoporose, hvor metodene omfatter administrering til en pasient med behov for dette av et 2-alkyliden-19-nor-vitamin D-derivat. Spesielt angår foreliggende oppfinnelse metoder for behandling av osteopeni eller mannlig osteoporose, hvor metodene omfatter administrering til en pasient med behov for dette av 2-metylen-19-nor-20(S)-1a,25dihydroksyvitamin D3.
NO20060655A 2003-09-19 2006-02-09 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn NO20060655L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50450803P 2003-09-19 2003-09-19
PCT/IB2004/002912 WO2005027917A1 (en) 2003-09-19 2004-09-06 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis

Publications (1)

Publication Number Publication Date
NO20060655L true NO20060655L (no) 2006-06-16

Family

ID=34375510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060655A NO20060655L (no) 2003-09-19 2006-02-09 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn

Country Status (17)

Country Link
US (1) US20050065125A1 (no)
EP (1) EP1667690A1 (no)
JP (1) JP2007505884A (no)
KR (1) KR20060058135A (no)
CN (1) CN100413507C (no)
AU (1) AU2004273667A1 (no)
BR (1) BRPI0414465A (no)
CA (1) CA2539358A1 (no)
HK (1) HK1092063A1 (no)
IL (1) IL173653A0 (no)
MX (1) MXPA06003156A (no)
NO (1) NO20060655L (no)
NZ (1) NZ545393A (no)
RU (1) RU2006108528A (no)
TW (1) TW200512000A (no)
WO (1) WO2005027917A1 (no)
ZA (1) ZA200602258B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1861419B1 (en) 2005-03-15 2011-06-29 Allergan, Inc. Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
WO2012112420A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Treatments using psma ligand endopeptidases
CN106974078A (zh) * 2017-03-22 2017-07-25 广东海洋大学 25‑oh‑d3促进21‑42日龄白羽肉鸡胫骨发育的应用
CN106857403A (zh) * 2017-03-22 2017-06-20 广东海洋大学 25‑oh‑d3促进1‑21日龄白羽肉鸡胫骨发育的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
DE69400495T2 (de) * 1993-04-05 1997-04-30 Wisconsin Alumni Res Found 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6316642B1 (en) * 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
EP1255732A1 (en) * 2000-01-31 2002-11-13 Leo Pharma A/S Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
IL152942A (en) * 2000-05-31 2007-09-20 Wisconsin Alumni Res Found Compounds 2 - Ethyl and 2 - Ethylaidine - 19 - Nur - Vitamin D and pharmaceutical preparations containing them
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone

Also Published As

Publication number Publication date
ZA200602258B (en) 2007-11-28
IL173653A0 (en) 2006-07-05
WO2005027917A1 (en) 2005-03-31
AU2004273667A1 (en) 2005-03-31
US20050065125A1 (en) 2005-03-24
RU2006108528A (ru) 2006-07-27
MXPA06003156A (es) 2006-06-05
JP2007505884A (ja) 2007-03-15
NZ545393A (en) 2009-10-30
BRPI0414465A (pt) 2006-11-14
CN1852717A (zh) 2006-10-25
KR20060058135A (ko) 2006-05-29
TW200512000A (en) 2005-04-01
EP1667690A1 (en) 2006-06-14
CA2539358A1 (en) 2005-03-31
HK1092063A1 (en) 2007-02-02
CN100413507C (zh) 2008-08-27

Similar Documents

Publication Publication Date Title
NO20061245L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
MXPA05012061A (es) Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad.
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
UY26130A1 (es) Compuestos para tratar la obesidad
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
NO20065984L (no) Forbindelser og sammensetninger som PPAR modulatorer
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
NO20055129L (no) Fenylsubstituerte karboksylsyrer
EA200802213A1 (ru) Способы лечения заболеваний крови
TW200611695A (en) Pyrrolopyridine derivatives
GB0222495D0 (en) Compounds
NO20065983L (no) Forbindelser og sammensetninger som PPAR modulatorer
TW200602330A (en) Compounds and compositions as PPAR modulators
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
NO20082096L (no) Azaindol-2-karboksamidderivativer
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application